DUBLIN--(BUSINESS WIRE)--The "LAMEA Cardiac Pacemaker Devices Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Latin America, Middle East and Africa Cardiac Pacemaker Market is expected to witness market growth of 5.2% CAGR during the forecast period (2017 - 2023).
A pacemaker is an electrical device and it is used to treat arrhythmias, which leads to irregular heartbeat. This device is fitted in the chest or abdomen to treat some unusual heart rhythms that may cause patient heart to either beat too slowly or skip beats. Growing prevalence of cardiovascular disorders in developed nations, rapidly growing cases of cardiac disease in underdeveloped nations, supportive government initiatives, and non-government organizations funding are the factors that are driving the growth of the cardiac pacemaker market.
Based on product, the market report segments the market into Implantable cardiac pacemakers and External cardiac pacemakers. Based on technology, the market covers Single-chamber cardiac pacemakers, Dual-chamber cardiac pacemakers, and Bi-ventricular cardiac pacemakers. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Cardiac Pacemaker market segments the market into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
- Abbott Laboratories (U.S.)
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology Co ltd
- Cook Medical Group
- Medico S.p.A
- LivaNova PL
- Osypka Medical GmbH
- Shree Pacetronix Ltd.
- Medline Industries, Inc.
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. LAMEA Cardiac Pacemaker Market
4. LAMEA Cardiac Pacemaker Market by Technology
5. LAMEA Cardiac Pacemaker Market by End User
6. LAMEA Cardiac Pacemaker Market by Country
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/9mlmnl/lamea_cardiac?w=4